Is It Perimenopause? Common Symptoms and What Can Help
Perimenopause can start years before your last period. Here's what's changing, the symptoms it can bring, and the treatments with real evidence behind them.
Read the articleCancer treatment can bring menopause on suddenly, and endocrine therapy can make symptoms stronger. Here are the options that fit a survivor's life.
For many breast cancer survivors, menopause doesn't arrive gradually. It can start abruptly with chemotherapy, ovarian suppression or surgery to remove the ovaries. Endocrine therapies such as tamoxifen and aromatase inhibitors, which many women take for five years or more, can make hot flashes, vaginal dryness and joint aches worse.
Dr. Menn knows this transition from both sides: as an OB/GYN who treats it, and as a long-term breast cancer survivor who went through premature menopause herself. The good news is that survivors have more evidence-based options than they're often told.
A sudden drop in estrogen tends to cause more intense symptoms than the gradual decline of a natural menopause. Aromatase inhibitors lower estrogen even further, and tamoxifen commonly causes hot flashes. Symptoms matter beyond comfort: they are one of the reasons women stop endocrine therapy early, which can affect cancer outcomes. Treating them is part of cancer care.
For women with a history of breast cancer, systemic hormone therapy is generally not recommended.[1] The Menopause Society's 2023 nonhormone position statement recommends several alternatives with good evidence:[2]
Vaginal and urinary symptoms are common after cancer treatment, especially on aromatase inhibitors, and they usually don't get better on their own. Vaginal moisturizers used regularly and lubricants for sex are the first step.[4] Pelvic floor physical therapy and vaginal dilators help when pain has led to muscle tension.
If those aren't enough, ACOG's clinical consensus says low-dose vaginal estrogen may be considered after a discussion of risks and benefits, including for women taking tamoxifen. For women on aromatase inhibitors, the decision should be shared among the patient, her gynecologist and her oncologist.[5] Oral ospemifene isn't recommended for survivors because it hasn't been studied enough in this group.[4]
The question isn't only “is it safe?” It's “what is safe enough for me, given my cancer, my treatment and how much this affects my life?” That answer is personal, and it belongs to you and your team together.
Early menopause and aromatase inhibitors can both speed up bone loss. Your oncology team may recommend bone density testing. Getting enough calcium, mainly from food, and enough vitamin D, along with strength and balance exercise, supports bone health.[6] Heart health deserves attention too: blood pressure, cholesterol and blood sugar checks with your primary care doctor.
Bring your cancer type and receptor status, the treatments you've had, your current endocrine therapy, and a list of every medicine and supplement. Name the one or two symptoms that bother you most. A menopause plan for a survivor should always be written to share with the oncologist, so everyone is working from the same page.
Finally, give yourself time. Many treatments take several weeks to show their full effect, and it's common to try more than one before finding the right fit. Keeping a simple symptom diary makes it easier to judge what is helping. And if a symptom is making it hard to continue endocrine therapy, say so early: there is almost always something else to try.
Tell your oncology team about symptoms that make it hard to stay on endocrine therapy. Don't stop a prescribed cancer medicine without talking to them. Seek prompt care for a new breast lump, bone pain that doesn't go away, or unexplained bleeding.
This article is general education for adults and is not a substitute for personal medical advice. If you have a medical emergency, call 911.
Perimenopause can start years before your last period. Here's what's changing, the symptoms it can bring, and the treatments with real evidence behind them.
Read the articleHeadlines from 2002 still shape how many women feel about hormone therapy. Two decades of follow-up have given a clearer, more nuanced picture.
Read the articleGenitourinary syndrome of menopause affects a large share of postmenopausal women, yet many never mention it. Here's what it is and how it's treated.
Read the article